共 50 条
- [31] Randomized, Double-Masked, Placebo-Controlled Dose Escalation Study of TAK-639 Topical Ophthalmic Solution in Subjects with Ocular Hypertension or Primary Open-Angle Glaucoma CLINICAL OPHTHALMOLOGY, 2020, 14 : 885 - 896
- [33] Corneal Biomechanics for Ocular Hypertension, Primary Open-Angle Glaucoma, and Amyloidotic Glaucoma: A Comparative Study by Corvis ST CLINICAL OPHTHALMOLOGY, 2022, 16 : 71 - 83
- [34] Multicenter, prospective, open-label, observational study of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension CLINICAL OPHTHALMOLOGY, 2012, 6 : 739 - 746
- [38] Unpreserved latanoprost in the treatment of open-angle glaucoma and ocular hypertension. A multicenter, randomized, controlled study JOURNAL FRANCAIS D OPHTALMOLOGIE, 2016, 39 (07): : 622 - 630